Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Generex Biotechnology Corporation (NASDAQ: GNBT)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Generex's Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio
Nov 02, 2009 08:31 AM |
GNBT
Generex Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice
Oct 29, 2009 06:26 PM |
GNBT
Trading Outlook for Generex Biotechnologies Corp. Issued by InvestorSoup.com
Oct 27, 2009 06:51 AM |
GNBT
,
HSP
,
MNKD
,
NVO
Generex Biotechnology Receives Purchase Order for Generex Oral-lyn(TM) for Algerian Market
Oct 21, 2009 09:31 AM |
GNBT
Generex: Going Concern Qualification
Oct 20, 2009 04:05 PM |
GNBT
Generex to Present Clincial Data at the 20th World Diabetes Congress of the International Diabetes Federation
Oct 20, 2009 09:31 AM |
GNBT
Generex Launches Generex Oral-lyn(TM) in Algeria
Oct 16, 2009 09:31 AM |
GNBT
Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
Oct 15, 2009 09:38 AM |
AZN
,
GNBT
,
INO
,
NVAX
Generex Announces USFDA Price Approval for Generex Oral-lyn(TM) in the Treatment IND Program
Oct 14, 2009 09:31 AM |
GNBT
Generex Biotechnology to Hold Conference Call On Thursday to Update Investors On Generex Oral-lyn(TM) and Other Corporate Activities
Oct 14, 2009 08:04 AM |
GNBT
More..
Generex to Raise $12.25 Million in Registered Direct Offering
Sep 15, 2009 10:55 AM |
GNBT
More..
Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter
Oct 20, 2009 04:10 PM |
AGEN
,
CVM
,
DNDN
,
GNBT
,
ONTY
StockPreacher.Com Issues Trading Outlook for Novadel Pharma Inc.
Sep 25, 2009 07:57 AM |
GNBT
,
HSP
,
NVD
Mentor Capital Cancer Immunotherapy Index Posts Second 20% Plus Monthly Gain Lead By ImmunoCellular Therapeutics
Sep 16, 2009 10:18 AM |
AGEN
,
CVM
,
DNDN
,
GNBT
,
ONTY
New Cancer Immunotherapy Index Posts 23% Gains Lead By Mentor Capital, Inc. And Oncothyreon
Aug 28, 2009 02:11 PM |
AGEN
,
CVM
,
DNDN
,
GNBT
,
ONTY
Generex Biotechnology Corporation's Synthetic Vaccine Platform Represented At International Swine Flu Conference
Aug 27, 2009 08:32 AM |
GNBT
Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine
Aug 24, 2009 02:25 PM |
GNBT
Generex Announces Sales Agreement With McCarthy and Sons Service
Aug 18, 2009 08:31 AM |
GNBT
Generex Raises $5.65 Million in a Registered Direct Offering of Common Stock
Aug 06, 2009 04:54 PM |
GNBT
Generex Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza
Aug 05, 2009 09:31 AM |
GNBT
Amgen Co-Founder to Act As Generex Chief Scientific Advisor; Generex Engages Dr. Joseph Rubinfeld to Spearhead the Company's Scientific Development and Commercialization Plans for Its Drug Delivery Platform and Vaccine Technologies
Aug 04, 2009 10:50 AM |
AMGN
,
GNBT
,
SUPG
More..
Form 4 GENEREX BIOTECHNOLOGY For: Oct 19 Filed by: Masterson Nola E (10K)
Oct 19, 2009 06:50 PM
Form 4 GENEREX BIOTECHNOLOGY For: Jan 12 Filed by: FLETCHER MARK (10K)
Jan 12, 2009 05:49 PM
Form 4 GENEREX BIOTECHNOLOGY For: Oct 31 Filed by: FLETCHER MARK (10K)
Nov 03, 2008 11:03 AM
Form 4 GENEREX BIOTECHNOLOGY For: May 27 Filed by: PERRI ROSE C (10K)
May 29, 2008 04:06 PM
Form 4 GENEREX BIOTECHNOLOGY For: May 27 Filed by: GLUSKIN ANNA E (10K)
May 29, 2008 04:06 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
GNBT
Compare to S&P
YTD
69.39 %
47.65 %
4 Weeks
-19.22 %
-20.07 %
12 Weeks
-17.70 %
-19.74 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
0.00 %
EPS Growth in Last Year:
-66.67 %
Sales Growth in Last Quarter:
175.00 %
Sales Growth in Last Quarter:
61.76 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
